How long does Wegovy take to kick in — and what should you actually expect?

The biggest misconception: Wegovy does not "kick in" the way a painkiller does

A lot of people expect a clear, early moment when Wegovy starts working, a switch that flips. That's not how it works, and expecting it can make the first few weeks feel disappointing. The medicine is active in your system from the first injection, but its effects accumulate across months of gradual dose increases. Nausea in week two is not a sign it isn't working; steady, quiet appetite reduction across weeks six to twelve is.

The starting dose, 0.25 mg, exists to let your digestive system adjust. Some people notice a modest reduction in hunger during this phase. Others feel little difference at all, which is entirely normal. The therapeutic work happens as the prescriber steps the dose upward, typically every four weeks, through 0.5 mg, 1.0 mg, 1.7 mg and eventually 2.4 mg. It is only at or near maintenance dose that most people experience the full effect on appetite and food intake.

If you are wondering how long semaglutide takes to kick in more broadly, the picture is the same regardless of the brand, the molecule, and its gradual build, are identical.

When most people start to see actual weight loss on Wegovy

Clinically, the period between weeks eight and sixteen is when body weight changes tend to become obvious. Appetite is genuinely reduced by this point for most people on an intermediate dose, calorie intake falls without requiring constant effort, and the scales begin to reflect it. That said, the rate of loss is not uniform, early weeks can show faster movement as fluid shifts occur, followed by steadier, slower fat loss over subsequent months.

The STEP 1 trial, published in the New England Journal of Medicine, followed adults with obesity taking semaglutide 2.4 mg over 68 weeks alongside lifestyle changes. Average weight reduction reached approximately 15%. That figure did not materialise at week four. It was the product of the full treatment arc, dose escalation, sustained appetite change, and consistent lifestyle adjustments working together.

For context on cost and what private treatment involves alongside that timeline, the Wegovy overview page covers pricing and what to expect from the process.

Factors that affect how quickly you personally notice a difference

Starting weight, individual metabolism, how closely a reduced-calorie approach is followed, and how your body tolerates each dose increase all influence the pace. People who experience significant nausea early in titration sometimes lose weight quickly in those first weeks, not because the medicine is working faster, but because eating less is almost unavoidable. That pattern tends to stabilise. People who tolerate each dose increase easily may notice slower early movement on the scales but more consistent loss over time.

It is worth being honest: if you are reading this at week three feeling nothing, that is a common and frustrating position. It does not mean the treatment is failing. The question our prescribers hear regularly is whether someone should push ahead or reconsider, and that is exactly the kind of clinical conversation that should happen with a prescriber, not based on an online forum at midnight.

The NHS semaglutide medicines page also addresses what to expect and when to seek help if something feels wrong. Worth bookmarking alongside your Patient Information Leaflet.

If you are comparing timelines across treatments, the detailed look at how long Wegovy takes to work covers the longer arc, and there is a related discussion on how fast Wegovy kicks in for people earlier in the process. Our guide on how long it takes for Wegovy to kick in goes further on what to realistically expect at each stage of dose escalation, and if you want to understand the broader medication picture, our page covering how long semaglutide takes to kick in explains why the timeline looks similar across all treatments using this molecule.

What to do if Wegovy does not seem to be working after several months

NICE's guidance on semaglutide (TA875) recommends reviewing whether to continue if less than 5% weight loss has occurred after six months on the maintenance dose. That threshold exists for a reason: it identifies people for whom this particular medicine may not be delivering meaningful benefit, freeing them to explore alternatives with clinical support rather than continuing indefinitely. The assessment is the prescriber's, based on your individual data, not a self-reported feeling.

At nume, every repeat order is clinically re-reviewed before dispatch, so there is a built-in checkpoint at each stage of treatment. If results are not moving in the expected direction, that conversation happens. Treatment is never just automatically renewed.

If you are at that point and thinking about your options, speaking to our prescribers is the practical next step. There is no clinical review fee at consultation, and the conversation is the same day. Start your free consultation to speak to our prescribers about your progress and what to do next.